Chemists Use Light to Signal Drug Release
Posted on: Monday, 14 March 2005, 06:00 CST
Virginia scientists believe they can use specific wavelengths of light to signal manmade molecules to release drugs when they reach disease sites in the body.
The light is in the red band, a set of wavelengths that are not normally absorbed or reflected away by cells.
Researchers at Virginia Tech in Blacksburg designed molecules that can hold drugs until they are delivered to sites of disease in the body. Once the molecules are in place, they are signaled using the light. The drugs then cleave the DNA in the target cell, for example a tumor cell.
The challenge has been that tissue blocks light so we can't signal molecules deep within the body to deliver drug therapy, says Karen Brewer, associate professor of chemistry and one of the paper's authors.
The work was presented in a poster session Sunday at the national meeting of the American Chemical Society in San Diego.
Source: United Press International
Related Articles
- First Pediatric Patient Treated With Aptocine(TM), a Novel Light-Activated Drug, in Neurofibromatosis Study
- Light Sciences Oncology Announces Results of Study on Immunotherapeutic Mechanism of Aptocine(TM), a Novel Light-Activated Drug Therapy for Cancer
- FDA Gives Clinical Trial Green Light on Drug to Treat Alzheimer's Disease
- Minn. Law Sheds Light on Drug Companies
- New Light-Initiated Drug Delivery Studied
- Roche Research Sheds Light on Drug Metabolism
- New Genetic Research Method Sheds Light on Drug Metabolism
- Geron Announces Presentation of New Data Supporting the Utility of Its Small Molecule Telomerase Activator Drugs for HIV/AIDS Therapy
- Engineered molecule amplifies body's immune response
 |
 |
User Comments (0)
RSS Feeds